1[1]Aradia FA, Smith RG, Rose DS, et al. Success rate of long-term circulatory assist devices used currently for bridge to heart transplantation.Amer Soc Artif Orgenes J, 1996,42:542 ～ 546.
2[2]Frazier OH. Mechanical circulatory support: new advance, new pump,new ideas. Seminars in Thorac Cardiovasc Surg,2002,14:178 ～ 186.
3[3]Robbins RC, Kown M H, Portner PM, et al. The total implantable novacor left ventricular assist system. Amt Thorac Surg, 1999,71:162 ～165.
4[4]Rose EA, Gelijns AC, Moskowitz A J, et al. Long-term use of left ventrieular assist device for end-stage heart failure. N Engl J Med,2001,345:1435 ～ 1443.
5[5]Frazier OH,Macris MP,Myers TJ, et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994,57:1416 ～ 1422.
6[6]Frazier OH. First use of an untethered,vented electric left ventricular assist device for long-term support. Circulation, 1994, 89:2908 ～2914.
7[7]Frazier OH ,Myers TJ. Left venrricular assist system as a bridge to myocardial recovery. Ann Thorac Surg, 1999,68:734 ～ 741.
8[8]Scheinin S, Capek P, Radovancevic B, et al. The effect of prolonged left ventricular assist support on myocardial histopathology in patients with end stage cardiomyopathy. ASAIO J, 1992,38:271 ～ 274.
9[9]Bruckner BA ,Stetson SJ, Farmer JA ,et al. The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. Am J Surg,2000, 180:495 ～ 502.
10[10]Torre-Amione G, Stetson SJ, Youker KA, et al. Deceased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support:a potential mechanism for cardiac recovery. Circulation, 1999,100:1189 ～ 1193.
